Home / Health / Ozempic Works Long-Term: Still Eating Less!
Ozempic Works Long-Term: Still Eating Less!
24 Jul
Summary
- Semaglutide users consistently ate fewer calories than placebo recipients.
- Weight loss averaged 15% for semaglutide patients over 60 weeks.
- Appetite sensations may return, but drug still cuts calorie intake.
A recent clinical trial found that semaglutide, a popular weight-loss medication, continues to significantly reduce calorie intake over extended periods. Participants taking semaglutide for 60 weeks consistently ate substantially fewer calories than those on a placebo, demonstrating a sustained effect. This sustained reduction in calorie intake, averaging 24% to 30% fewer calories, is a key factor in maintaining weight loss, with semaglutide users losing an average of 15% of their body weight. Interestingly, these results were observed even though participants reported a partial return of hunger sensations after several months of treatment, highlighting a distinction between perceived appetite and actual food consumption.
